macro

BMO Capital cuts price targets on Ingevity and Intuit, keeps Outperform ratings

BMO Capital kept Outperform ratings on Ingevity and Intuit but lowered price targets to $72 and $375. Source: TradingView, data from Benzinga.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

BMO Capital retained its Outperform rating on Ingevity but reduced its price target from $85 to $72, a cut of 15.3%. The new target implies 28.7% upside from the November 19 close of $55.96.

The same bank also kept Intuit at Outperform, while trimming its target from $412 to $375, a 9.0% reduction. That target points to 21.0% upside from the November 19 close of $310.02.

According to TradingView, which relies on Benzinga data, Intuit has drawn five recent analyst notes over the past 30 days. On November 20, Wells Fargo held Equal-Weight with a $320 target, Barclays held Overweight at $385, RBC Capital held Outperform at $330, TD Cowen reiterated Hold at $350, and Morgan Stanley held Equal-Weight at $310. Targets in that group range from $310 to $385.

why it matters

Analyst price-target revisions are routine news. The ratings themselves did not change, so the market reaction is usually limited. Investors tend to focus more on company earnings and guidance than on a single bank's valuation.

tags

instruments

IngevityIntuit

sources

  1. BMO Capital maintains Ingevity at Outperform, lowers price target to $72 from $85 — TradingView, 20 November 2026 at 16:30 UTC
  2. BMO Capital maintains Intuit at Outperform, lowers price target to $375 from $412 — TradingView, 20 November 2026 at 16:29 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗